Clinical Pharmacokinetics of Zidovudine
Authors:
- 1 July 1989
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 17 (1) , 1-9
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- ZidovudineDrugs, 1989
- Pharmacokinetics and bioavailability of zidovudine in humans.1988
- Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid.The Journal of Pharmacology and Experimental Therapeutics, 1988
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseasesClinical Pharmacology & Therapeutics, 1987
- Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitroAntimicrobial Agents and Chemotherapy, 1987
- Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.Proceedings of the National Academy of Sciences, 1986
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1986
- Developmental Aspects of Drug Conjugation, with Special Reference to GlucuronidationAnnual Review of Pharmacology and Toxicology, 1978
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977